Amag

FDA

Marketing

FDA proposes yanking approval for AMAG Pharma's Makena

The FDA proposed withdrawing marketing approval for AMAG's Makena just days after the company agreed to a $647 million buyout from Clovis Group.

Kyle Blankenship Oct 6, 2020 11:32am

FDA Building 2

Call for FDA to pull preterm birth med splits doctors, insurers

Jan 27, 2020 9:26am

boardroom

AMAG's move to cut CEO, 2 drugs may not save it: analyst

Jan 9, 2020 4:00pm